Larry Rubinstein

66.5k citations
196 papers · 47.6k · 7 hit papers · h-index 54

Impact in

  • Oncology top 0.01%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Colorectal Cancer Treatments and Studies 24
    • PARP inhibition in cancer therapy 18
    • Cancer therapeutics and mechanisms 14
    • DNA Repair Mechanisms 13

Larry Rubinstein

185 papers receiving 46.7k citations

Larry Rubinstein's Hit Papers

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) 2008 · 20.7k citations
20.7k0+14+28Years since publication5.0k10.0k15.0k20.0k

Peers

Larry Rubinstein
Comparison fields: 5 of 191
  • Oncology 22.4k
  • Pulmonary and Respiratory Medicine 20.2k
  • Hepatology 4.2k
  • Cancer Research 7.3k
  • Radiology, Nuclear Medicine and Imaging 7.4k
Replace Richard Kaplan with:
Richard Kaplan United Kingdom
Lawrence H. Schwartz United States
Susan G. Arbuck United States
Daniel J. Sargent United States
Janet Dancey United States
Jean‐Pierre Pignon France
Lalitha Shankar United States
Jan Bogaerts Belgium
Jaap Verweij Netherlands
Elizabeth A. Eisenhauer Canada
Larry Rubinstein relative to Richard Kaplan United Kingdom Richard Kaplan's profile →
Citations per field
00.5×1.5×
Richard Kaplan · 1×
Citations per year

Countries citing papers authored by Larry Rubinstein

Since Specialization
Citations

This map shows the geographic impact of Larry Rubinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Rubinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Rubinstein more than expected).

Fields of papers citing papers by Larry Rubinstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry Rubinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Rubinstein. The network helps show where Larry Rubinstein may publish in the future.

Co-authors

The 25 scholars most cited alongside Larry Rubinstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Larry Rubinstein Line = papers co-authored together Larry Rubinstein links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 196 papers — load more, or switch the sort, to bring in the rest.

#Work
1
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
Hit paper breakdown →
200820737
2
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Hit paper breakdown →
200013583
3
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer
Hit paper breakdown →
19952113
4
Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines
Hit paper breakdown →
1990859
5
Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm
Hit paper breakdown →
1989816
6
Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
Hit paper breakdown →
2001621
7
Modern thirty-day operative mortality for surgical resections in lung cancer
Hit paper breakdown →
1983511
8 2005476
9 1997433
10 2005315
11 2005258
12 1984246
13 1992239
14 2009229
15 2017214
16 1999202
17 1981191
18 2020190
19 1990188
20 1994179

About Larry Rubinstein

Larry Rubinstein is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Statistics and Probability and Cancer Research, having authored 196 papers that have together received 47.6k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (41 papers), Cancer Genomics and Diagnostics (33 papers), Lung Cancer Treatments and Mutations (28 papers), Colorectal Cancer Treatments and Studies (24 papers), Health Systems, Economic Evaluations, Quality of Life (20 papers), PARP inhibition in cancer therapy (18 papers), Cancer therapeutics and mechanisms (14 papers) and DNA Repair Mechanisms (13 papers). The work is most often cited by research in Oncology (22.4k citations), Pulmonary and Respiratory Medicine (20.2k citations), Hepatology (4.2k citations), Cancer Research (7.3k citations) and Radiology, Nuclear Medicine and Imaging (7.4k citations). Larry Rubinstein has collaborated with scholars based in United States, Malaysia and Canada. Frequent co-authors include Susan G. Arbuck, Richard Kaplan, Michaele C. Christian, Daniel J. Sargent, Janet Dancey, Lori E. Dodd, Lawrence H. Schwartz, Margaret Mooney, Lalitha Shankar and Jan Bogaerts. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, JNCI Journal of the National Cancer Institute, Cancer Research and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact